Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | IMGN151 |
| Trade Name | |
| Synonyms | IMGN-151|IMGN 151 |
| Drug Descriptions |
IMGN151 is an antibody-drug conjugate (ADC) comprising an anti-FOLR1 (FRalpha) antibody linked to a maytansinoid-derivative, which potentially leads to killing of tumor cells expressing FOLR1 and reduced tumor growth (Cancer Res (2020) 80 (16_Supplement): 2890). |
| DrugClasses | FOLR1-targeted Therapy 24 |
| CAS Registry Number | NA |
| NCIT ID | C191851 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bevacizumab + IMGN151 | Bevacizumab IMGN151 | 0 | 1 |
| Carboplatin + IMGN151 | Carboplatin IMGN151 | 0 | 1 |
| IMGN151 | IMGN151 | 0 | 2 |
| IMGN151 + Olaparib | IMGN151 Olaparib | 0 | 1 |